Vertex Pharmaceuticals Inc / Ma

FIRST TRUST ADVISORS LP VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

201,290

Value ($000)

91,257

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	91,257	0.1%	201,290	12/31/2025
2025 Q3	11/12/2025	73,691	0.1%	188,161	9/30/2025
2025 Q2	8/13/2025	128,170	0.1%	287,892	6/30/2025
2025 Q1	5/14/2025	70,206	0.1%	144,808	3/31/2025
2024 Q4	2/13/2025	77,635	0.1%	192,786	12/31/2024
2024 Q3	11/13/2024	267,436	0.3%	575,032	9/30/2024
2024 Q2	8/13/2024	95,310	0.1%	203,341	6/30/2024
2024 Q1	5/13/2024	96,643	0.1%	231,197	3/31/2024
2023 Q4	2/13/2024	298,997	0.3%	734,835	12/31/2023
2023 Q3	11/13/2023	277,624	0.3%	798,366	9/30/2023
2023 Q2	8/14/2023	102,046	0.1%	289,977	6/30/2023
2023 Q1	5/15/2023	104,851	0.1%	332,786	3/31/2023
2022 Q4	2/9/2023	101,065	0.1%	349,971	12/31/2022
2022 Q3	11/14/2022	104,492	0.1%	360,892	9/30/2022
2022 Q2	8/12/2022	290,084	0.4%	1,029,432	6/30/2022
2022 Q1	5/13/2022	115,039	0.1%	440,812	3/31/2022
2021 Q4	2/8/2022	114,505	0.1%	521,427	12/31/2021
2021 Q3	11/15/2021	89,003	0.1%	490,671	9/30/2021
2021 Q2	10/12/2021	80,518	0.1%	399,314	6/30/2021
2021 Q1	5/14/2021	83,287	0.1%	387,580	3/31/2021
2020 Q4	2/2/2021	95,486	0.1%	404,019	12/31/2020
2020 Q3	11/5/2020	225,795	0.4%	829,763	9/30/2020
2020 Q2	7/22/2020	235,748	0.4%	812,055	6/30/2020
2020 Q1	5/6/2020	117,886	0.3%	495,422	3/31/2020
2019 Q4	2/3/2020	78,160	0.1%	356,976	12/31/2019
2014 Q2	8/11/2014	93,369	0.4%	986,152	6/30/2014
2014 Q1	5/12/2014	55,697	0.2%	787,573	3/31/2014
2013 Q4	8/8/2014	47,086	0.2%	633,724	12/31/2013